HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Osinaga Selected Research

Acetylgalactosamine

1/2009Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.
9/2006UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells.
3/2006UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Osinaga Research Topics

Disease

39Neoplasms (Cancer)
01/2022 - 01/2003
16Breast Neoplasms (Breast Cancer)
11/2021 - 02/2003
10Carcinoma (Carcinomatosis)
07/2021 - 01/2003
7Colonic Neoplasms (Colon Cancer)
12/2021 - 07/2005
4Carcinogenesis
04/2016 - 03/2004
3Neoplasm Metastasis (Metastasis)
07/2018 - 01/2001
2Echinococcosis (Hydatid Cysts)
12/2021 - 09/2004
2Parasitic Diseases (Parasitic Disease)
04/2016 - 04/2007
2Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2014 - 03/2013
2Aberrant Crypt Foci
06/2010 - 07/2005
2Adenocarcinoma
12/2005 - 07/2005
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
04/2020
1Celiac Disease (Celiac Sprue)
04/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Infections
03/2013
1Neuroblastoma
01/2013
1Metaplasia
01/2009
1Fibroadenoma
03/2006
1Noninfiltrating Intraductal Carcinoma (DCIS)
03/2006
1Breast Diseases (Breast Disease)
03/2006
1Starvation
12/2005

Drug/Important Bio-Agent (IBA)

16AntigensIBA
12/2021 - 01/2003
15MucinsIBA
07/2018 - 01/2003
9Tn antigenIBA
10/2021 - 01/2003
7Polysaccharides (Glycans)IBA
01/2022 - 01/2003
7Peptides (Polypeptides)IBA
11/2021 - 09/2003
6Monoclonal AntibodiesIBA
11/2021 - 03/2006
6CarbohydratesIBA
10/2021 - 09/2005
6Polypeptide N-acetylgalactosaminyltransferaseIBA
07/2018 - 01/2003
5AntibodiesIBA
12/2021 - 01/2013
5LectinsIBA
10/2021 - 02/2003
5EnzymesIBA
01/2013 - 12/2005
5Messenger RNA (mRNA)IBA
09/2006 - 02/2003
4Proteins (Proteins, Gene)FDA Link
06/2010 - 03/2006
4Glycoproteins (Glycoprotein)IBA
03/2008 - 09/2003
3VaccinesIBA
01/2022 - 03/2013
3Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2005
3Interleukin-10 (Interleukin 10)IBA
10/2021 - 03/2004
3Biological ProductsIBA
07/2021 - 12/2005
3CytokinesIBA
04/2020 - 03/2004
3Dimenhydrinate (DMH)FDA LinkGeneric
04/2016 - 07/2005
3AcetylgalactosamineIBA
01/2009 - 03/2006
3Uridine Diphosphate (UDP)IBA
01/2009 - 03/2006
3apomucinIBA
03/2006 - 09/2003
2Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
01/2022 - 07/2012
2Immunoglobulin G (IgG)IBA
12/2021 - 08/2011
2TransferasesIBA
11/2021 - 09/2004
2Tumor Biomarkers (Tumor Markers)IBA
05/2016 - 08/2005
2Small Interfering RNA (siRNA)IBA
05/2016 - 10/2008
21,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
04/2016 - 06/2010
2Galectin 1 (LGALS1)IBA
01/2014 - 02/2013
2Cancer VaccinesIBA
09/2013 - 06/2013
2N-AcetylgalactosaminyltransferasesIBA
09/2006 - 03/2006
2GlycosyltransferasesIBA
09/2006 - 09/2005
2Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
12/2005 - 03/2004
2Carcinoembryonic AntigenIBA
08/2005 - 02/2003
2Keratin-19 (Keratin 19)IBA
08/2005 - 02/2003
1Interleukin-5 (Interleukin 5)IBA
12/2021
1Galactose (Galactopyranose)FDA LinkGeneric
10/2021
1ChitosanIBA
07/2021
1Docetaxel (Taxotere)FDA Link
07/2021
1Pharmaceutical PreparationsIBA
07/2021
1NanocapsulesIBA
07/2021
1UDP-N-acetylgalactosamine polypeptide N-acetylgalactosaminyltransferase 6IBA
07/2018
1ErbB Receptors (EGF Receptor)IBA
01/2017
1Immunoconjugates (Immunoconjugate)IBA
07/2016
1auristatinIBA
07/2016
1SaporinsIBA
07/2016
1Interleukin-6 (Interleukin 6)IBA
05/2016
1methylureaIBA
04/2016
1NADPH Oxidases (NAD(P)H oxidase)IBA
04/2016
1Papillomavirus Vaccines (HPV Vaccines)IBA
04/2014
1GangliosidesIBA
01/2014
1Oxygen (Dioxygen)IBA
01/2014
1Amino AcidsFDA Link
06/2013
1DNA (Deoxyribonucleic Acid)IBA
03/2013
1Carrier Proteins (Binding Protein)IBA
02/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2011
1Fc Receptors (Fc Receptor)IBA
08/2011
1LigandsIBA
06/2010
1Galectin 3 (LGALS3)IBA
06/2010
1GalactosamineIBA
05/2010
1CaspasesIBA
10/2008
1SurvivinIBA
10/2008
1Formaldehyde (Formol)FDA Link
03/2006
1Immune Sera (Antisera)IBA
03/2006
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
12/2005
1Heme (Haem)IBA
12/2005
1Heme Oxygenase-1IBA
12/2005
1Recombinant ProteinsIBA
09/2005
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2005
1CarcinogensIBA
07/2005
1Coloring Agents (Dyes)IBA
07/2005
1N-Acetylneuraminic Acid (Sialic Acid)IBA
07/2005
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2004
1Metalloproteases (Metalloproteinases)IBA
03/2004
1ChemokinesIBA
03/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2004

Therapy/Procedure

9Therapeutics
01/2022 - 01/2001
5Immunotherapy
01/2022 - 03/2004